Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Pancreatic Neoplasms 8 Ovarian Neoplasms 5 Mesothelioma, Malignant 4 Carcinoma, Non-Small-Cell Lung 4 Lung Neoplasms 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Stomach Neoplasms 2 Neoplasms 2 Mesothelioma 2 Melanoma 2 Glioblastoma 2 Uveal Melanoma 1 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Phase IB 1 Non Hematologic Cancers 1 Neoplasms, Mesothelial 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mesonephric Gynecologic Cancer 1 Lymphoma 1 Low-Grade Serous Ovarian Cancer 1 Low Grade Serous Ovarian Cancer 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1

Interventions

Temozolomide 163 Radiosurgery 128 Radiotherapy 106 Bevacizumab 97 Magnetic Resonance Spectroscopy 74 Carboplatin 48 Surgical Procedures, Operative 35 Etoposide 34 pembrolizumab 33 Radiation 33 Nivolumab 33 Irinotecan 33 Cyclophosphamide 33 Erlotinib Hydrochloride 31 Carmustine 28 Trastuzumab 25 Lomustine 25 Cisplatin 25 Ipilimumab 24 Filgrastim 23 Mental Status and Dementia Tests 21 Magnetic Resonance Imaging 21 Aminolevulinic Acid 21 Vincristine 20 Surveys and Questionnaires 19 Capecitabine 19 Topotecan 18 Specimen Handling 18 Pemetrexed 18 Radiotherapy, Intensity-Modulated 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × defactinib × Clear all

NCT06194929 2025-12-03

DETERMINE

University of Utah

Phase 1/2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡